NYSE$CLB

Core Laboratories Inc · Q2 2023 earnings

Q2 2023 earnings · · Investor relations

Headline financials

Total Revenue

$128M

No prior period
EPS

$0.48

No prior period
Capital Expenditures

-$2.18M

No prior period
Free Cash Flow

$20.7M

No prior period
Net Income

$22.8M

No prior period
Operating Income

$18.9M

No prior period
Gross Profit

$1.5M

No prior period
Cash & Equivalents

$26.2M

No prior period
Total Assets

$602M

No prior period

Revenue & EPS history

Core Labs · Revenue · Quarterly

$128M

Q2 2023
Beat estimate in 1 of 2 quarters(50%)
ActualEstimate

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 9 quarterly earnings reports · overlaid with Q2 2023

Historical avgQ2 2023

+4.1%

Avg return

Earnings day

+2.8%

Avg return

5 days after

-3.7%

Avg return

30 days after

67%

6 / 9 earnings

Positive

+28.8%

Q3 2025

Best reaction

-15.3%

Q1 2026

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026-15.3%-17.7%-21.2%
Q4 2025-4.2%-4.9%-18.9%
Q3 2025+28.8%+29.0%+15.3%
Q1 2025+2.2%-2.1%-6.5%
Q3 2024+10.9%+14.2%+24.6%
Q2 2024+10.6%+11.2%-16.6%
Q1 2024+3.3%-4.4%+8.4%
Q3 2023+1.1%-10.8%-14.0%
Q2 2023-0.8%+10.6%-4.4%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro